Last reviewed · How we verify

NCT04881097: COGNI

Cognitive Function and Health-related Quality of Life After Neuro-intensive Care

Withdrawn Last updated 8 November 2022
What this trial tests

trial testing no intervention in Acute Brain Injury. Withdrawn.

Timeline
1 August 2021
Primary endpoint
1 August 2024
1 August 2025

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusWithdrawn
Study typeOBSERVATIONAL
Start date1 August 2021
Primary completion1 August 2024
Estimated completion1 August 2025

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 18 to 110, any sex, with Acute Brain Injury or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Acute Brain Injury

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04881097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing